Does NEBIVOLOL Cause Wrong technique in product usage process? 114 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Wrong technique in product usage process have been filed in association with NEBIVOLOL (nebivolol). This represents 1.8% of all adverse event reports for NEBIVOLOL.
114
Reports of Wrong technique in product usage process with NEBIVOLOL
1.8%
of all NEBIVOLOL reports
0
Deaths
19
Hospitalizations
How Dangerous Is Wrong technique in product usage process From NEBIVOLOL?
Of the 114 reports, 19 (16.7%) required hospitalization.
Is Wrong technique in product usage process Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 114 reports have been filed with the FAERS database.
What Other Side Effects Does NEBIVOLOL Cause?
Hypotension (487)
Drug ineffective (430)
Bradycardia (371)
Dyspnoea (364)
Fall (320)
Acute kidney injury (300)
Dizziness (294)
Off label use (277)
Fatigue (257)
Hypertension (249)
What Other Drugs Cause Wrong technique in product usage process?
EVOLOCUMAB (21,664)
ALBUTEROL (17,114)
ADALIMUMAB (11,766)
PEGFILGRASTIM (10,217)
ETANERCEPT (9,835)
ERENUMAB-AOOE (9,359)
SACUBITRIL\VALSARTAN (8,022)
LEUPROLIDE (5,062)
FENTANYL (2,812)
SEMAGLUTIDE (2,538)
Which NEBIVOLOL Alternatives Have Lower Wrong technique in product usage process Risk?
NEBIVOLOL vs NECITUMUMAB
NEBIVOLOL vs NEDAPLATIN
NEBIVOLOL vs NEFAZODONE
NEBIVOLOL vs NEFOPAM
NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG